Title of article :
Apixaban successfully resolved a warfarin-resistant left atrial appendage thrombus in a patient with end-stage renal disease on hemodialysis
Author/Authors :
Min Park, Yae Division of Cardiology - Department of Internal Medicine - Gachon University Gil Medical Center - Incheon - Republic of Korea , Moon, Jeonggeun Division of Cardiology - Department of Internal Medicine - Gachon University Gil Medical Center - Incheon - Republic of Korea , Chung, Wook-Jin Division of Cardiology - Department of Internal Medicine - Gachon University Gil Medical Center - Incheon - Republic of Korea , Shin, Mi-Seung Division of Cardiology - Department of Internal Medicine - Gachon University Gil Medical Center - Incheon - Republic of Korea , Choi, In Suck Division of Cardiology - Department of Internal Medicine - Gachon University Gil Medical Center - Incheon - Republic of Korea
Abstract :
The left atrial appendage (LAA) is the major source of thromboembolism in patients with atrial fibrillation (AF). Warfarin or
new oral anticoagulants (NOACs) have been used to treat the LAA
thrombus; however, the use of NOACs is limited in patients with
renal dysfunction. Here, we report the case of a patient with paroxysmal AF and end-stage renal disease (ESRD) requiring hemodialysis, in whom apixaban successfully and safely resolved a LAA
thrombus refractory to warfarin.
Keywords :
atrial fibrillation , factor Xa inhibitor , apixaban , left atrial appendage thrombus , end stage renal disease
Journal title :
The Anatolian Journal of Cardiology: Andolu Kardiyoloji Dergisi
